POSaBIT Systems Corp. · CSE:PBIT
POSaBIT Systems — Investor Presentation (March 2023)
22 slides from POSaBIT Systems's investor presentation, March 2023
Slide 1: Investor Presentation
Investor Presentation CSE: PBIT OTC: POSAF March 2023
Slide 2: Disclaimer
Disclaimer This presentation has been prepared solely for the benefit and use of certain qualifying investors. This presentation is confidential and proprietary, and may not be disclosed, reproduced, distributed or used for any other purpose without the express written consent of POSaBIT. IMPORTANT
Slide 3: Company Overview
Company Overview Investor Presentation 3
Slide 4: At a Glance
At a Glance Founded in 2015, POSaBIT is the leading payments and point of sale provider for the cannabis industry. Upon completion of the Akerna Acquisition1, we reach 900+ locations in 27 states. Core offering Locations Active in PAYMENTS + POS 500+ 23 STATES 2 Publicly Traded 2023 GUIDANCE CSE: PB
Slide 5: Overview
Overview Milestones • $20M guaranteed POS licensing agreement executed in 2022 • Announced acquisition of MJ Freeway and Ample Organic assets in 2023 • Total lifetime dollars raised: $19.8MM Current Offerings Future Offerings • PIN Debit Payments • Cultivation & Processing • Retail and Mobile Point
Slide 6: POSaBIT Timeline
POSaBIT Timeline 2023 2021 Announcement of 2015 2017 2019 OTC Listing, Full Acquisition, POSaBIT Payments launch in POSaBIT Goes Payment Infrastructure Released Established WA & CO Public on the CSE and Reporting POSaBIT POS 2.0 2015–2016 2018 2020 2022 First Fully-Compliant, Launches Full First Ful
Slide 7: POSaBIT Leadership Team
POSaBIT Leadership Team Board of Directors Ryan Hamlin CEO / Co-founder / Chairman Bruce Jaffe Director Ryan Hamlin Andy Sweet Julie Solomon Matt Fowler Co-Founder/CEO Chief Technology Officer Chief Revenue Officer Chief Financial Officer 1 Mike Apker Director Don Tringali Director Louis Camhi Direc
Slide 8: Key Growth Drivers
Key Growth Drivers • New Merchants • Same-store Growth • State Legalization • Digital Payments Penetration • Acquisitions • Partnerships • New Offerings Investor Presentation: Company Overview 8
Slide 9: Why Merchants Choose POSaBIT
Why Merchants Choose POSaBIT Open API Platform Built and Delivered by POSaBIT ● Flexibility to work with partners you want ● Products developed in house: we’re best to support ● Not locked in to one provider ● POSaBIT has full control over SLAs and roadmap ● Easy integration ● Superior experience fo
Slide 10: Point of Sale Competition (w/Akerna acquisition)
Point of Sale Competition (w/Akerna acquisition) POSaBIT Dutchie BioTrack Treez Blaze Retail Point-of-Sale ✓ ✓ ✓ ✓ Cultivation, Manufacturing & ✓ ✓ ✓ Distribution Software Payments and Reporting ✓ ✓ ✓ State Traceability System ✓ Investor Presentation: Company Overview 10
Slide 11: Payments Competition
Payments Competition Unlike typical retail, cash is king • Customers artificially limit their spending power by taking out Leading PIN Leading ACH ATMs Non-compliant cash prior to their purchase. POSaBIT Debit Provider Only Platform (cash) (Credit/POB) • With a cap on their spending Full Regulatory
Slide 12: Robust National Presence
Robust National Presence POSaBIT has dispensary partners in 23 states across the country. States with POSaBIT Customers Investor Presentation: Company Overview 12
Slide 13: Partnerships
Partnerships State Compliance POS and Loyalty eCommerce Data and Compliance Investor Presentation: Company Overview 13
Slide 14: Investment Highlights
Investment Highlights Investor Presentation 14
Slide 15: The Opportunity
The Opportunity Current Market (Big) Future Market (Massive) • More than ¾ of the US population resides • States that recently passed cannabis in a state that legalized cannabis legislation, markets not yet open • >11,800 medical and recreational • Continued expansion in current legal dispensaries i
Slide 16: Financial Overview
Financial Overview Note: 2022 Year End Financials will be updated after the April 26, 2023, Earning Release Investor Presentation 16
Slide 17: Q3 2022 Results
Q3 2022 Results in US dollars Three months ended Nine months ended Sept 30, Sept 30, % Sept 30, Sept 30, % 2022 2021 Change 2022 2021 Change Revenue $10,330,937 $6,363,578 62.3% $24,920,606 $14,868,253 67.6% Cost of good sold 7,436,410 4,935,039 50.7% 18,537,204 10,591,899 75.0% Gross profit 2,894,5
Slide 18: 2023 Guidance
2023 Guidance * Total revenue: Adjusted EBITDA: Gross profit Dollars: $60M to $63M Positive $15 - $17M *Represents a non-IFRS measure. Investor Presentation: Financial Overview 18
Slide 19: Quarterly Financials
Quarterly Financials Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 Gross $26.7M $42.2M $47.3M $64M $87.3M $111.9M $105.6M $102.5M $129.2M $143.5M Transactional Sales Revenue $1.5M $2.3M $3.1M $3.5M $5.0M $6.4M $6.4M $6.4M $8.2M $10.3M Gross Profit $292K $575.1K $767
Slide 20: Yearly Financials
Yearly Financials 2022 1 2020 2021 GUIDANCE Gross Transactional Sales $132M $368.8M $600-$700M Growth Rates 144% 179% 76%* Revenue $7.8M $21.3M $37-40M Growth Rates 129% 173% 81%* Gross Profit $1.74M $5.76 $10-10.5M Gross Margin 22% 231% 78%* *Measured at the mid-point (1) See “Financial Outlook” In
Slide 21: Summary Balance Sheet
Summary Balance Sheet As of As of Sept 30, 2022 Dec 31, 2021 Cash $8,159,289 $4,418,788 Total Current Assets $4,065,470 $3,146,444 Non-Current Assets $ 403,849 $ 338,543 Total Assets $12,628,608 $7,903,775 Total Current Liabilities $ 9,449,174 $5,873,959 Non-Current Liabilities $5,546,000 $10,736,95
Slide 22: Thank you
Thank you (ch POSaBIT